chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Chills, Headache
Clinical narrative: lower back pain; Joint pain; Dull headache; Intense chills exactly 12 hours after the dose; No energy; Shaking; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (No energy), TREMOR (Shaking), BACK PAIN (lower back pain), CHILLS (Intense chills exactly 12 hours after the dose) and ARTHRALGIA (Joint pain) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced ASTHENIA (No energy), TREMOR (Shaking) and CHILLS (Intense chills exactly 12 hours after the dose). On 06-May-2021, the patient experienced BACK PAIN (lower back pain), ARTHRALGIA (Joint pain) and HEADACHE (Dull headache). At the time of the report, ASTHENIA (No energy), TREMOR (Shaking), BACK PAIN (lower back pain), ARTHRALGIA (Joint pain) and HEADACHE (Dull headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-114430 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: lower back pain; Joint pain; Dull headache; Intense chills exactly 12 hours after the dose; No energy; Shaking; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (No energy), TREMOR (Shaking), BACK PAIN (lower back pain), CHILLS (Intense chills exactly 12 hours after the dose) and ARTHRALGIA (Joint pain) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced ASTHENIA (No energy), TREMOR (Shaking) and CHILLS (Intense chills exactly 12 hours after the dose). On 06-May-2021, the patient experienced BACK PAIN (lower back pain), ARTHRALGIA (Joint pain) and HEADACHE (Dull headache). At the time of the report, ASTHENIA (No energy), TREMOR (Shaking), BACK PAIN (lower back pain), ARTHRALGIA (Joint pain) and HEADACHE (Dull headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-114430 (Patient Link).
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Area around injection site feels hot; Area around injection site is swollen/Swelling seems more pronounced at night; Swelling seems more pronounced at night; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Area around injection site feels hot), VACCINATION SITE SWELLING (Area around injection site is swollen/Swelling seems more pronounced at night) and VACCINATION SITE SWELLING (Swelling seems more pronounced at night) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PHENYTOIN (DILANTIN [PHENYTOIN]), TOPIRAMATE, VITAMIN D3 and FOLIC ACID for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced VACCINATION SITE WARMTH (Area around injection site feels hot), VACCINATION SITE SWELLING (Area around injection site is swollen/Swelling seems more pronounced at night) and VACCINATION SITE SWELLING (Swelling seems more pronounced at night). At the time of the report, VACCINATION SITE WARMTH (Area around injection site feels hot), VACCINATION SITE SWELLING (Area around injection site is swollen/Swelling seems more pronounced at night) and VACCINATION SITE SWELLING (Swelling seems more pronounced at night) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment includes ice pack to painful site.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in hand) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A7LB or 037A7RB and 016CZLA) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUTICASONE for an unknown indication.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in hand). On 11-Apr-2021, PAIN IN EXTREMITY (Pain in hand) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Relevant concomitant medications included spray for seasonal allergies.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-114451 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114451:Second Dose Case
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate, Vertigo, Vomiting
Clinical narrative: Extreme dizzy; Felt room spinning; Vomiting; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (Extreme dizzy), VERTIGO (Felt room spinning) and VOMITING (Vomiting) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (Extreme dizzy), VERTIGO (Felt room spinning) and VOMITING (Vomiting). At the time of the report, DIZZINESS (Extreme dizzy), VERTIGO (Felt room spinning) and VOMITING (Vomiting) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: normal (normal) normal. On an unknown date, Laboratory test: negative (Negative) They ran all tests and everything came back negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided. No concomitant medications were reported.  The patient called her neighbour who is a nurse she called EMT and they checked her BP and heart rate was normal so the patient declined to go to hosp. Next morning, the patient was eating bowl of strawberries in her home and it started all over again. This time EMT was called and the patient went to Hospital.  They ran all tests and everything came back negative. The patient came back home the same afternoon. After that it never happened and The patient is fine since then.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Additional information received contains non-significant information. On 26-Jul-2021: Additional information added and narrative updated about granddaughters dose.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Myalgia
Clinical narrative: She also has all over body soreness as if she has been exercising; ear pain; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (ear pain) and MYALGIA (She also has all over body soreness as if she has been exercising) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 026B21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic pain.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced EAR PAIN (ear pain). On 06-May-2021, the patient experienced MYALGIA (She also has all over body soreness as if she has been exercising). At the time of the report, EAR PAIN (ear pain) had resolved and MYALGIA (She also has all over body soreness as if she has been exercising) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that she has been taking pain medications for chronic pain. Treatment included Pain medications for ear pain.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Myalgia
Clinical narrative: a little redness on shoulder; Muscle pain ("a lot stronger"); Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (a little redness on shoulder), MYALGIA (Muscle pain ("a lot stronger")) and ARTHRALGIA (Joint pain) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included Biopsy in 2004. Concurrent medical conditions included Myopathy (Tubular Aggregate Myopathy) since 2004 and Allergy. Concomitant products included MORPHINE, CARISOPRODOL (SOMA [CARISOPRODOL]), HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN), HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), DIGOXIN, SOTALOL, OLMESARTAN MEDOXOMIL (BENICAR), EZETIMIBE (ZETIA), ADENOSINE (TRICOR [ADENOSINE]), OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]), VITAMIN D [VITAMIN D NOS], MAGNESIUM, VITAMIN B1 NOS, LORATADINE and PSEUDOEPHEDRINE for an unknown indication.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced ERYTHEMA (a little redness on shoulder), MYALGIA (Muscle pain ("a lot stronger")) and ARTHRALGIA (Joint pain). At the time of the report, ERYTHEMA (a little redness on shoulder), MYALGIA (Muscle pain ("a lot stronger")) and ARTHRALGIA (Joint pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-114419 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114419:Case for first dose
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Pruritus, Rash
Clinical narrative: Redness; Hypersensitivity reaction; Itching; Rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching), HYPERSENSITIVITY (Hypersensitivity reaction), ERYTHEMA (Redness) and RASH (Rash) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Hypercholesterolaemia and Hypothyroidism. Concomitant products included PRAVASTATIN for High cholesterol, METOPROLOL for Hypertension, LEVOTHYROXINE for Hypothyroidism, CYANOCOBALAMIN (B12 1000 SR) and CALCIUM for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PRURITUS (Itching) and RASH (Rash). On 13-Feb-2021, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction). On an unknown date, the patient experienced ERYTHEMA (Redness). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) ongoing from 01-Mar-2021 for Rash and Itching, at a dose of 10 mg once a day. At the time of the report, PRURITUS (Itching), HYPERSENSITIVITY (Hypersensitivity reaction), ERYTHEMA (Redness) and RASH (Rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient saw a new doctor who gave the Medrol Dose Pak but told not to take it until 3 weeks after the second shot.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow up received on 08-may-2021 contains no new information. On 08-Jun-2021: Follow up received on 8-JUN-2021.Patient's demographics, medical history, concomitants  and second dose details were updated. On 12-Jul-2021: Follow-up received and contains no new information On 22-Jul-2021: Follow up received on 22-JUL-2021. No new information was received.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Chills, Headache, Pyrexia
Clinical narrative: Loss of taste; Headache; Feverish; Chills; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste), HEADACHE (Headache), PYREXIA (Feverish) and CHILLS (Chills) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 003B71A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced AGEUSIA (Loss of taste), HEADACHE (Headache), PYREXIA (Feverish) and CHILLS (Chills). At the time of the report, AGEUSIA (Loss of taste), HEADACHE (Headache), PYREXIA (Feverish) and CHILLS (Chills) outcome was unknown.            Reporter did not allow further contact
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site swelling, Nausea
Clinical narrative: fatigue; swelling at the injection site; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (swelling at the injection site), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. MOD020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced INJECTION SITE SWELLING (swelling at the injection site), HEADACHE (headache) and NAUSEA (nausea). On 18-Apr-2021, the patient experienced FATIGUE (fatigue). On 19-Apr-2021, INJECTION SITE SWELLING (swelling at the injection site), HEADACHE (headache) and NAUSEA (nausea) had resolved. On 22-Apr-2021, FATIGUE (fatigue) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant and treatment details were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-114464 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114464:crosslinked; wife case
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Headache, Pain, Pyrexia
Clinical narrative: shivering; Pyrexia; headache; body aches all over; stomach problems; fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach problems), PYREXIA (fever), CHILLS (shivering), PYREXIA (Pyrexia) and HEADACHE (headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (fever). On 04-May-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach problems), CHILLS (shivering), PYREXIA (Pyrexia), HEADACHE (headache) and PAIN (body aches all over). On 30-Apr-2021, PYREXIA (fever) had resolved. On 05-May-2021, ABDOMINAL DISCOMFORT (stomach problems), CHILLS (shivering) and PYREXIA (Pyrexia) had resolved. At the time of the report, HEADACHE (headache) and PAIN (body aches all over) had not resolved.            No concomitant medications were reported.  Treatment details included tums.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Headache, Myalgia, Neck pain
Clinical narrative: Pain on back; Pain on hips; Headache; Generalized pain on body; Pain on arm; Pain on neck; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PAIN IN EXTREMITY (Pain on arm), BACK PAIN (Pain on back), ARTHRALGIA (Pain on hips) and NECK PAIN (Pain on neck) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #037A7LB) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FLUTICASONE and (unspecified)                                                  Spray for seasonal allergies for an unknown indication.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced NECK PAIN (Pain on neck). On 09-May-2021, the patient experienced HEADACHE (Headache), PAIN IN EXTREMITY (Pain on arm), BACK PAIN (Pain on back), ARTHRALGIA (Pain on hips) and MYALGIA (Generalized pain on body). At the time of the report, HEADACHE (Headache), PAIN IN EXTREMITY (Pain on arm), BACK PAIN (Pain on back), ARTHRALGIA (Pain on hips), NECK PAIN (Pain on neck) and MYALGIA (Generalized pain on body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-114441 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114441:First Dose Case
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain on back; Pain on hips; Headache; Generalized pain on body; Pain on arm; Pain on neck; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PAIN IN EXTREMITY (Pain on arm), BACK PAIN (Pain on back), ARTHRALGIA (Pain on hips) and NECK PAIN (Pain on neck) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #037A7LB) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FLUTICASONE and (unspecified)                                                  Spray for seasonal allergies for an unknown indication.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced NECK PAIN (Pain on neck). On 09-May-2021, the patient experienced HEADACHE (Headache), PAIN IN EXTREMITY (Pain on arm), BACK PAIN (Pain on back), ARTHRALGIA (Pain on hips) and MYALGIA (Generalized pain on body). At the time of the report, HEADACHE (Headache), PAIN IN EXTREMITY (Pain on arm), BACK PAIN (Pain on back), ARTHRALGIA (Pain on hips), NECK PAIN (Pain on neck) and MYALGIA (Generalized pain on body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-114441 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114441:First Dose Case
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: sleepy since receiving their first Moderna COVID-19 vaccination; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy since receiving their first Moderna COVID-19 vaccination) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN, CARVEDILOL (CARVEDIOL), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN and LISINOPRIL for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced SOMNOLENCE (sleepy since receiving their first Moderna COVID-19 vaccination). At the time of the report, SOMNOLENCE (sleepy since receiving their first Moderna COVID-19 vaccination) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lethargy, Malaise, Myalgia
Clinical narrative: Lethargy; Not feeling the best; Chills; Fever; tired; Arm hurt more from second shot than the first; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), MALAISE (Not feeling the best), PAIN IN EXTREMITY (Arm hurt more from second shot than the first), MYALGIA (Sore arm) and CHILLS (Chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B2/A and 013A2/A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concurrent medical conditions included Asthma, Chronic kidney disease stage 3, Blood pressure high, Depression, Nasal allergy, Allergy to chemicals (scented or fumes) and Drug allergy (Tylenol).   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced MYALGIA (Sore arm). On 02-May-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt more from second shot than the first). On an unknown date, the patient experienced LETHARGY (Lethargy), MALAISE (Not feeling the best), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (tired). On 03-Apr-2021, MYALGIA (Sore arm) had resolved. On 03-May-2021, PAIN IN EXTREMITY (Arm hurt more from second shot than the first) had resolved. At the time of the report, LETHARGY (Lethargy), CHILLS (Chills) and PYREXIA (Fever) had resolved and MALAISE (Not feeling the best) and FATIGUE (tired) outcome was unknown.      No concomitant medication were reported.  No treatment medications were reported.  Recent status of current condition was Stage 3 kidney disease improved, high blood pressure fairly stable and depression cause Increased Prozac dos. Patient states that Viral Infection can be a cause.   This case was linked to MOD-2021-046355 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Added patient demographics, relevant history, Batch/Lot number and Events.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Lethargy; Not feeling the best; Chills; Fever; tired; Arm hurt more from second shot than the first; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), MALAISE (Not feeling the best), PAIN IN EXTREMITY (Arm hurt more from second shot than the first), MYALGIA (Sore arm) and CHILLS (Chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B2/A and 013A2/A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concurrent medical conditions included Asthma, Chronic kidney disease stage 3, Blood pressure high, Depression, Nasal allergy, Allergy to chemicals (scented or fumes) and Drug allergy (Tylenol).   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced MYALGIA (Sore arm). On 02-May-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt more from second shot than the first). On an unknown date, the patient experienced LETHARGY (Lethargy), MALAISE (Not feeling the best), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (tired). On 03-Apr-2021, MYALGIA (Sore arm) had resolved. On 03-May-2021, PAIN IN EXTREMITY (Arm hurt more from second shot than the first) had resolved. At the time of the report, LETHARGY (Lethargy), CHILLS (Chills) and PYREXIA (Fever) had resolved and MALAISE (Not feeling the best) and FATIGUE (tired) outcome was unknown.      No concomitant medication were reported.  No treatment medications were reported.  Recent status of current condition was Stage 3 kidney disease improved, high blood pressure fairly stable and depression cause Increased Prozac dos. Patient states that Viral Infection can be a cause.   This case was linked to MOD-2021-046355 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Added patient demographics, relevant history, Batch/Lot number and Events.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pain in extremity
Clinical narrative: arm hurt; soreness in the back of her shoulder blade; dull headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), ARTHRALGIA (soreness in the back of her shoulder blade) and HEADACHE (dull headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 026B21A) for COVID-19 vaccination.     No medical history information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced HEADACHE (dull headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt) and ARTHRALGIA (soreness in the back of her shoulder blade). At the time of the report, PAIN IN EXTREMITY (arm hurt), ARTHRALGIA (soreness in the back of her shoulder blade) and HEADACHE (dull headache) outcome was unknown.            No concomitant medications were reported. Patient was reported to be taking pain medications as treatment.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased, Neck mass, Neck pain, Vaccination site mass
Clinical narrative: pain in neck; Swollen lump on neck; Swollen bump at injection site on left arm; Shortness of breath; Rapid heartbeat; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain in neck), NECK MASS (Swollen lump on neck), VACCINATION SITE MASS (Swollen bump at injection site on left arm), DYSPNOEA (Shortness of breath) and HEART RATE INCREASED (Rapid heartbeat) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced NECK PAIN (pain in neck), NECK MASS (Swollen lump on neck), VACCINATION SITE MASS (Swollen bump at injection site on left arm), DYSPNOEA (Shortness of breath), HEART RATE INCREASED (Rapid heartbeat) and VACCINATION SITE PAIN (Pain at injection site). On 08-May-2021, DYSPNOEA (Shortness of breath) and HEART RATE INCREASED (Rapid heartbeat) had resolved. At the time of the report, NECK PAIN (pain in neck), NECK MASS (Swollen lump on neck), VACCINATION SITE MASS (Swollen bump at injection site on left arm) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.            Concomitant medications included Depression medications.  treatment information was not provided   The action taken with mRNA-1273 with the events was considered as not applicable  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments   This case was linked to MOD-2021-114428 (Patient Link).
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain in neck; Swollen lump on neck; Swollen bump at injection site on left arm; Shortness of breath; Rapid heartbeat; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain in neck), NECK MASS (Swollen lump on neck), VACCINATION SITE MASS (Swollen bump at injection site on left arm), DYSPNOEA (Shortness of breath) and HEART RATE INCREASED (Rapid heartbeat) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced NECK PAIN (pain in neck), NECK MASS (Swollen lump on neck), VACCINATION SITE MASS (Swollen bump at injection site on left arm), DYSPNOEA (Shortness of breath), HEART RATE INCREASED (Rapid heartbeat) and VACCINATION SITE PAIN (Pain at injection site). On 08-May-2021, DYSPNOEA (Shortness of breath) and HEART RATE INCREASED (Rapid heartbeat) had resolved. At the time of the report, NECK PAIN (pain in neck), NECK MASS (Swollen lump on neck), VACCINATION SITE MASS (Swollen bump at injection site on left arm) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.            Concomitant medications included Depression medications.  treatment information was not provided   The action taken with mRNA-1273 with the events was considered as not applicable  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments   This case was linked to MOD-2021-114428 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patient given an expired vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient given an expired vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient given an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient given an expired vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication information was reported.   This case was linked to MOD21-088361, MOD21-088351, MOD21-088359 (E2B Linked Report). This case was linked to MOD-2021-114420, MOD-2021-114641, MOD-2021-114834 (Patient Link).; Sender's Comments:  MOD21-088361: MOD21-088351: MOD21-088359:
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vision blurred
Clinical narrative: Blurred vision; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurred vision) and DIZZINESS (Dizziness) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced VISION BLURRED (Blurred vision) and DIZZINESS (Dizziness). At the time of the report, VISION BLURRED (Blurred vision) and DIZZINESS (Dizziness) outcome was unknown. Not Provided          No relevant Concomitant Medications were reported. No Treatment Information Provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient has not received their second Moderna Covid-19 vaccine yet and it has been greater than; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient has not received their second Moderna Covid-19 vaccine yet and it has been greater than) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has not received their second Moderna Covid-19 vaccine yet and it has been greater than). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient has not received their second Moderna Covid-19 vaccine yet and it has been greater than) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided.  No treatment medication provided.  patient went to receive  2 dose of vaccine after 90 days.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up information received on 10 JUN  2021 contain No New  Information.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Bleeding like having a period; Spot; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (Bleeding like having a period) and VAGINAL HAEMORRHAGE (Spot) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced VAGINAL HAEMORRHAGE (Bleeding like having a period) and VAGINAL HAEMORRHAGE (Spot). At the time of the report, VAGINAL HAEMORRHAGE (Bleeding like having a period) and VAGINAL HAEMORRHAGE (Spot) outcome was unknown. Not Provided
Sex: M
Vaccine: COVID19
Symptoms: Infectious mononucleosis
Clinical narrative: tested positive for mononucleosis; This spontaneous case was reported by a consumer and describes the occurrence of INFECTIOUS MONONUCLEOSIS (tested positive for mononucleosis) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 since an unknown date. Concomitant products included AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AMOXICILLIN & CLAV. POTASSIUM), CETIRIZINE, FAMOTIDINE, CYCLOBENZAPRINE and PREDNISONE for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFECTIOUS MONONUCLEOSIS (tested positive for mononucleosis). At the time of the report, INFECTIOUS MONONUCLEOSIS (tested positive for mononucleosis) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Infectious mononucleosis: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Chromaturia, Dizziness, Dyspnoea
Clinical narrative: Dizziness; Vertigo; Severe abdominal pain; Shortness of breath; Skin had pallor; Urine was dark; Stool was lighter; lethargy; Generalized body aches; Generalized weakness; localized pain in injection arm; extreme fatigue/fatigue; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness), VERTIGO (Vertigo), ABDOMINAL PAIN (Severe abdominal pain), DYSPNOEA (Shortness of breath) and PALLOR (Skin had pallor) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cholecystitis (surgically removed about one month after the vaccine was given.).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), VERTIGO (Vertigo), ABDOMINAL PAIN (Severe abdominal pain), DYSPNOEA (Shortness of breath), PALLOR (Skin had pallor), CHROMATURIA (Urine was dark), FAECES PALE (Stool was lighter), LETHARGY (lethargy), PAIN (Generalized body aches), ASTHENIA (Generalized weakness), INJECTION SITE PAIN (localized pain in injection arm) and FATIGUE (extreme fatigue/fatigue). At the time of the report, DIZZINESS (Dizziness), VERTIGO (Vertigo), ABDOMINAL PAIN (Severe abdominal pain), DYSPNOEA (Shortness of breath), PALLOR (Skin had pallor), CHROMATURIA (Urine was dark), FAECES PALE (Stool was lighter), LETHARGY (lethargy), PAIN (Generalized body aches), ASTHENIA (Generalized weakness), INJECTION SITE PAIN (localized pain in injection arm) and FATIGUE (extreme fatigue/fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Hepatic enzyme: high (High) bloodwork showed that  liver enzymes were high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow up received on 09-Aug-2021 and new event added.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Faeces pale, Fatigue, Hepatic enzyme, Injection site pain, Lethargy
Clinical narrative: Dizziness; Vertigo; Severe abdominal pain; Shortness of breath; Skin had pallor; Urine was dark; Stool was lighter; lethargy; Generalized body aches; Generalized weakness; localized pain in injection arm; extreme fatigue/fatigue; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness), VERTIGO (Vertigo), ABDOMINAL PAIN (Severe abdominal pain), DYSPNOEA (Shortness of breath) and PALLOR (Skin had pallor) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cholecystitis (surgically removed about one month after the vaccine was given.).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), VERTIGO (Vertigo), ABDOMINAL PAIN (Severe abdominal pain), DYSPNOEA (Shortness of breath), PALLOR (Skin had pallor), CHROMATURIA (Urine was dark), FAECES PALE (Stool was lighter), LETHARGY (lethargy), PAIN (Generalized body aches), ASTHENIA (Generalized weakness), INJECTION SITE PAIN (localized pain in injection arm) and FATIGUE (extreme fatigue/fatigue). At the time of the report, DIZZINESS (Dizziness), VERTIGO (Vertigo), ABDOMINAL PAIN (Severe abdominal pain), DYSPNOEA (Shortness of breath), PALLOR (Skin had pallor), CHROMATURIA (Urine was dark), FAECES PALE (Stool was lighter), LETHARGY (lethargy), PAIN (Generalized body aches), ASTHENIA (Generalized weakness), INJECTION SITE PAIN (localized pain in injection arm) and FATIGUE (extreme fatigue/fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Hepatic enzyme: high (High) bloodwork showed that  liver enzymes were high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow up received on 09-Aug-2021 and new event added.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pallor, Vertigo
Clinical narrative: Dizziness; Vertigo; Severe abdominal pain; Shortness of breath; Skin had pallor; Urine was dark; Stool was lighter; lethargy; Generalized body aches; Generalized weakness; localized pain in injection arm; extreme fatigue/fatigue; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness), VERTIGO (Vertigo), ABDOMINAL PAIN (Severe abdominal pain), DYSPNOEA (Shortness of breath) and PALLOR (Skin had pallor) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cholecystitis (surgically removed about one month after the vaccine was given.).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), VERTIGO (Vertigo), ABDOMINAL PAIN (Severe abdominal pain), DYSPNOEA (Shortness of breath), PALLOR (Skin had pallor), CHROMATURIA (Urine was dark), FAECES PALE (Stool was lighter), LETHARGY (lethargy), PAIN (Generalized body aches), ASTHENIA (Generalized weakness), INJECTION SITE PAIN (localized pain in injection arm) and FATIGUE (extreme fatigue/fatigue). At the time of the report, DIZZINESS (Dizziness), VERTIGO (Vertigo), ABDOMINAL PAIN (Severe abdominal pain), DYSPNOEA (Shortness of breath), PALLOR (Skin had pallor), CHROMATURIA (Urine was dark), FAECES PALE (Stool was lighter), LETHARGY (lethargy), PAIN (Generalized body aches), ASTHENIA (Generalized weakness), INJECTION SITE PAIN (localized pain in injection arm) and FATIGUE (extreme fatigue/fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Hepatic enzyme: high (High) bloodwork showed that  liver enzymes were high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow up received on 09-Aug-2021 and new event added.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Pain in extremity, Thinking abnormal, Visual impairment
Clinical narrative: Pressure in the head; Unable to think clearly; Vision Problem; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Pressure in the head), THINKING ABNORMAL (Unable to think clearly), VISUAL IMPAIRMENT (Vision Problem) and PAIN IN EXTREMITY (Sore Arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included ATENOLOL for Hypertension.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (Pressure in the head), THINKING ABNORMAL (Unable to think clearly), VISUAL IMPAIRMENT (Vision Problem) and PAIN IN EXTREMITY (Sore Arm). At the time of the report, HEAD DISCOMFORT (Pressure in the head), THINKING ABNORMAL (Unable to think clearly), VISUAL IMPAIRMENT (Vision Problem) and PAIN IN EXTREMITY (Sore Arm) outcome was unknown. Not Provided          Treatment information was not provided. The patient states that she thinks that the Moderna COVID-19 vaccine is a toxin to her body. She also states that the vaccine has propylene gycol which according to her is a carcinogen.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MOD-2021-114293 (Patient Link).; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.